Privacy policy

Consent of User

By using this Organon USA Inc. site, you agree with the terms of this Privacy Policy. Whenever you submit information to Organon USA Inc. through this site, you consent to the collection, use, and disclosure of that information in agreement with this Privacy Policy.

Information from Children

This site is not intended for children under 18 years of age. Organon USA Inc. will not knowingly collect personal information from visitors in this age category, and strongly advises parents to talk to their children about sharing information on the Web.

User Requirement(s)

You may use this web site without revealing any personal information, except when necessary for Organon USA Inc. to provide you with the product or service that you may have requested.

Collection of Personally Identifiable Data

Organon USA Inc. respects the privacy of visitors to this online site. We only collect personally identifiable data, such as your name, address, telephone number or e-mail address, when it is voluntarily submitted to us, through registration, completion of forms or e-mails, as part of an order for products or services, inquiries or requests about materials being ordered and similar situations in which you have chosen to provide the information to us.

The personal information you provide will enable us to offer you a tailored user experience, including personalized special offers, and information, products, and services that are relevant to your needs and interests.

Organon USA Inc. may disclose your personally identifiable data to third parties, located in the United States and/or any other country, if they are,

Contractors we use to support our business (e.g. technical support, delivery services, and financial institutions), in which case Organon USA Inc. will require these third parties to agree to treat personally identifiable data in accordance with this Privacy Policy.

In connection with the sale, assignment, or transfer of the business of this site to which the information relates, in which case Organon USA Inc. will require such buyer(s) to agree to treat all personally identifiable data in accordance with this Privacy Policy; or

Where required by applicable laws, court orders, or government regulations.

Organon USA Inc. will not sell your personally identifiable information to any third party without your consent.

Retention of Personally Identifiable Data

Once you have provided personally identifiable information to Organon USA Inc., we will store and maintain this voluntary information as long as you have not directed us otherwise, or for as long as the law requires us. The retention of your personally identifiable data allows Organon USA Inc. to continually provide site visitors with highly personalized services without interruption.

Security of Personally Identifiable Data

The personal and/or registration information that you provide to this Organon USA Inc. site is stored on a secure server that resides behind a firewall. The firewall is designed to block access of this data to parties outside of this site.

However, please be aware that the world wide web is a publicly accessible system, so each time information is made available online by you, there is a risk that it may get lost in transition or even be accessed by unauthorized third persons.

Right of Access and Correction

You have the right to review and/or modify any personally identifiable data stored in our system, if you believe it to be out of date or incorrect. To access and/or modify your personally identifiable data, please call 1-800-241-8812.

Right of Cancellation

At any time, you have the right to withdraw your consent of the use of your personal data, now or in the future. To withdraw your consent of the use of your personal data, please call 1-800-241-8812.

Collection of Passive Information

Organon USA Inc. may use information in aggregate or cumulative form to track the total number of visitors to this site, the number of visitors to each page of our site, and the domain names of our visitor's Internet service providers.

The aggregate information that is collected includes, but is not limited to, traffic patterns, site usage information and visitor information. This information is gathered to help develop the design and functionality of Organon USA Inc. sites, and allows us to personalize future visit.

Organon USA Inc. monitors customer traffic patterns and analyze our customers' likes and dislikes, so that we can continue to improve our services to site visitors.

Use of Passive Information Collected

Organon USA Inc. may use this information, which will always remain in aggregate form, to understand how our visitors use our Web site.

This information may be used to improve the content on our site, to customize the site to our users preferences, to communicate information to them, for marketing and research purposes, and for any other purpose that may be specified in this Privacy Policy.

No personally identifiable information is available in this process.

Sharing Passive information with third parties

Organon USA Inc. may share aggregate statistical information regarding our traffic patterns and site usage with our partners. We will not provide third parties with any individually identifiable personal information about customers without their express permission.

Occasionally, we use third parties/contractors to provide or track the usage of sponsored links that are seen on Organon USA Inc. sites. We do not permit these third parties to collect personal information from our customers without the customer's explicit permission.

If sharing of data with a third party occurs, Organon USA Inc. will ensure that the processing is performed according to the purposes and within the limits under which the data was originally gathered.

Links to Other Web Sites

This Web site may contain links to other Web sites as a service to our visitors. Please be aware that we have no control over these sites and our privacy policy does not apply to these sites.

Privacy Policy Revisions

Any changes to this privacy policy will be posted to this page. Please check back from time to time, especially before you provide any personally identifiable information.

Follistim^® AQ (follitropin beta injection) is approved to help women who have problems with ovulation. Follistim® AQ will not help women whose ovaries do not work at all (primary ovarian failure). Follistim^® AQ is also for women that are in an assisted reproductive technology (ART) program, such as in vitro fertilization.

Important Safety Information:

Always follow your health care professional’s dosing instructions when administering Follistim^® AQ Cartridge. Your health care professional has individualized the dose to be administered based on your medical history. Do not change your dose unless instructed by your health care professional.

Do not use Follistim^® AQ if you are allergic to recombinant human FSH products; have primary ovarian failure (your ovaries do not work at all); are pregnant or think you might be pregnant; have uncontrolled thyroid or adrenal gland problems; have tumors in your ovaries, breasts, uterus, hypothalamus, or pituitary gland; have heavy or irregular vaginal bleeding and the cause is not known; have ovarian cysts or enlarged ovaries not due to polycystic ovary syndrome (PCOS); or are allergic to streptomycin or neomycin. Follistim^® AQ may contain traces of these antibiotics and may cause allergic reactions.

Follistim^® AQ may cause ovarian hyperstimulation syndrome (OHSS), which is a serious medical problem that can happen when the ovaries are overstimulated. In rare cases it has caused death. OHSS causes fluid to build up suddenly in the stomach and chest areas. OHSS may occur after treatment with Follistim^® AQ. Call your health care professional right away if you get any of the following symptoms: severe pelvic pain (lower stomach area), nausea, vomiting, sudden weight gain, or reduced urine output.

Follistim^® AQ and other FSH products may cause serious lung problems including fluid in the lungs, trouble breathing, and worsening of asthma. Follistim^® AQ and other FSH products may also cause blood clots in blood vessels. This can lead to blood vessel problems (thrombophlebitis), stroke, loss of limb, or a blood clot in the lung (pulmonary embolus).

Follistim^® AQ and other FSH products can cause multiple births. Your health care professional will discuss your chances of multiple births.

Follistim^® AQ should only be prescribed by physicians experienced in infertility treatments.

Other side effects with Follistim^® AQ include stomach pain, gas, pelvic pain, nausea, breast pain, injection site problems, enlarged stomach area, back pain, constipation, headache, and ovarian pain. If you get any side effects that concern you, call your health care professional. These are not all the side effects of Follistim^® AQ. Contact your doctor or other health care professional without delay if you are experiencing symptoms including significant abdominal pain or if symptoms develop some days after the last injection has been given.

Please click here for important Product Information on Follistim^® AQ Cartridge.

Please click here for important Product Information on Follistim^® AQ Vial.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

Pregnyl^® (chorionic gonadotropin for injection, USP) is approved to induce ovulation and pregnancy in women who have problems with ovulation and who have been appropriately pretreated with human menopausal gonadotropins (medications containing follicle-stimulating hormone [FSH] and luteinizing hormone [LH]). Pregnyl^® will not help women whose ovaries do not work at all (primary ovarian failure).

Important Safety Information:
Do not use Pregnyl^® if you are allergic to human chorionic gonadotropin.

Pregnyl^® should be used in conjunction with human menopausal gonadotropins. Pregnyl^® should only be prescribed by physicians experienced in infertility treatments.

Pregnyl^® may cause ovarian hyperstimulation syndrome (OHSS), which is a serious medical problem that can happen when the ovaries are overstimulated. In rare cases it has caused death. OHSS causes fluid to build up suddenly in the stomach and chest areas. OHSS may occur after treatment with Pregnyl^®. Call your health care professional right away if you get any of the following symptoms: severe pelvic pain (lower stomach area), nausea, vomiting, sudden weight gain, or reduced urine output.

Pregnyl^® may also cause rupture of ovarian cysts resulting in internal bleeding (hemoperitoneum), multiple births, and artery blockage by a blood clot (arterial thromboembolism).

Other side effects with Pregnyl^® include headache, irritability, restlessness, depression, fatigue, edema, and pain at the site of injection. If you get any side effects that concern you, call your health care professional.

Please click here for important Product Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

Ganirelix Acetate Injection is approved for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.

Important Safety Information:
Do not use Ganirelix Acetate Injection if you are allergic to ganirelix acetate or any of its components, gonadotropin releasing hormone (GnRH) or any other GnRH analog (including GnRH agonists and antagonists), or if you are pregnant or think you might be pregnant.

Ganirelix Acetate Injection should only be prescribed by physicians experienced in infertility treatments. Before starting treatment with Ganirelix, pregnancy must be excluded.

Hypersensitivity (allergic) reactions, some severe, have been reported after the first dose of Ganirelix Acetate Injection. Call your health care professional right away if you get any of the following symptoms: hives, difficulty breathing, chest tightness, high or low blood pressure, vomiting, or diarrhea. The packaging of this product contains natural rubber latex which may cause allergic reactions.

Ganirelix Acetate Injection may cause ovarian hyperstimulation syndrome (OHSS), which is a serious medical problem that can happen when the ovaries are overstimulated. In rare cases it has caused death. OHSS causes fluid to build up suddenly in the stomach and chest areas. Call your health care professional right away if you get any of the following symptoms: severe pelvic pain (lower stomach area), nausea, vomiting, sudden weight gain, or reduced urine output.

Other side effects with Ganirelix Acetate Injection include abdominal pain, death of unborn child, headache, vaginal bleeding, injection site reaction, and nausea. If you get any side effects that concern you, call your health care professional.

Please click here for important Product Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.